AI assistant
Sending…
Medivir — Major Shareholding Notification 2017
Mar 14, 2017
3177_iss_2017-03-14_33b3f1f1-b2cb-4e26-b747-a86eb900339a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Medivir Aktiebolag
Holder
Paradigm Capital Value Fund SICAV
Instrument
| Instrument | Class B shares and redemption shares | |
|---|---|---|
| Before the transaction | ||
| Shares | 1,349,128 | |
| Voting rights | 1,349,128 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 10/03/2017 | |
| Limit for number of shares | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,058,033 | |
| Directly held voting rights | 1,058,033 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 3.924 % | |
| Directly held voting rights | 3.263 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 3.263 % | 1,058,033 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 3.263 % | 1,058,033 |
| Group total holdings Voting rights 1,058,033 Percentage of voting rights 3.263 |
||
| Published 14/03/2017 17:49 Contact Name Rahul Dcunha Phone +49 89 620 21 78 18 Email [email protected] |
||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Medivir
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
AGM Information
2026
May 7
AGM Information
2026
May 7
Interim / Quarterly Report
2026
May 5
Interim / Quarterly Report
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 2